EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Global estimates on the number of persons across the Alzheimer's disease continuum

Anders Gustavsson, Nicholas Norton, Thomas Fast, Lutz Frölich, Jean Georges, Drew Holzapfel, Tunahan Kirabali, Pierre Krolak-Salmon, Paolo M Rossini, Maria Teresa Ferretti, Lydia Lanman, Antonella Santuccione Chadha und 1 weitere

Alzheimer's & Dementia · 2023-02 · 19 (2) · 658-670

DOI: 10.1002/alz.12694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 02.06.2022. Verfasst von Anders Gustavsson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 911-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: F. Hoffmann-La Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Global estimates on numbers of persons in early stages of Alzheimer's disease (AD), including prodromal and preclinical, are lacking, yet are needed to inform policy decisions on preventive measures and planning for future therapies targeting AD pathology.

Methods

We synthesized the literature on prevalence across the AD continuum and derived a model estimating the number of persons, stratified by 5‐year age groups, sex, and disease stage (AD dementia, prodromal AD, and preclinical AD).

Results

The global number of persons with AD dementia, prodromal AD, and preclinical AD were estimated at 32, 69, and 315 million, respectively. Together they constituted 416 million across the AD continuum, or 22% of all persons aged 50 and above.

Discussion

Considering predementia stages, the number of persons with AD is much larger than conveyed in available literature. Our estimates are uncertain, especially for predementia stages in low‐ and middle‐income regions where biomarker studies are missing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansBiomarkersPrevalenceProdromal Symptoms

Stichwörter der Autor:innen

Alzheimer's diseasepreclinicalprevalencepreventionprodromal

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.
  • Quantify Research, Stockholm, Sweden.
  • Department of Geriatric Psychiatry, Central Institute of Mental Health Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Alzheimer Europe, Luxembourg.
  • CEO Initiative on Alzheimer's Disease, Philadelphia, USA.
  • Biogen International GmbH, Baar, Switzerland.

Förderung

  • F. Hoffmann-La Roche

Zitieren

APA

Gustavsson, A., Norton, N., Fast, T., Frölich, L., Georges, J., Holzapfel, D., Kirabali, T., Krolak-Salmon, P., Rossini, P. M., Ferretti, M. T., Lanman, L., Chadha, A. S., & van der Flier, W. M. (2023). Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimer's & Dementia, 19(2), 658-670. https://doi.org/10.1002/alz.12694

Vancouver

Gustavsson A, Norton N, Fast T, Frölich L, Georges J, Holzapfel D, et al. Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimer's & Dementia. 2023;19(2):658-670. doi:10.1002/alz.12694

BibTeX
@article{Gustavsson2023,
  author = {Gustavsson, Anders and Norton, Nicholas and Fast, Thomas and Frölich, Lutz and Georges, Jean and Holzapfel, Drew and Kirabali, Tunahan and Krolak-Salmon, Pierre and Rossini, Paolo M and Ferretti, Maria Teresa and Lanman, Lydia and Chadha, Antonella Santuccione and van der Flier, Wiesje M},
  title = {Global estimates on the number of persons across the Alzheimer's disease continuum},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {2},
  pages = {658--670},
  doi = {10.1002/alz.12694}
}
Kostenlos starten →